Gelnique Warnings and Precautions

Specific Gelnique Warnings and Precautions

Some warnings and precautions to be aware of prior to taking Gelnique include the following:
 
  • Gelnique could transfer from one person to another if vigorous skin-to-skin contact occurs (such as during sexual intercourse). In order to prevent this, cover the application with clothing once the gel has dried.
     
  • Gelnique is flammable. Avoid smoking or open flame until the gel has dried.
     
  • Gelnique can slow down the digestive system. This can cause problems, especially for people who already have a slow digestive system due to other medical problems.
     
  • This medication can make glaucoma worse. If you have glaucoma and take Gelnique, your healthcare provider may need to monitor you more closely.
     
  • The kidneys and liver help to remove Gelnique from your body. If you have kidney or liver disease, you may require extra monitoring by your healthcare provider and may need to take a lower Gelnique dosage.
     
  • Gelnique can cause blurred vision, dizziness, and drowsiness. Make sure to see how Gelnique affects you before driving or operating heavy machinery.
     
  • Gelnique can decrease your ability to sweat, which may increase your risk of heat stroke. Make sure to stay well hydrated in the heat.
     
  • Gelnique may potentially interact with a number of other medications (see Gelnique Drug Interactions).
     
  • Gelnique is considered a pregnancy Category B medication. This means that it is probably safe for use during pregnancy, although the full risks are not known (see Gelnique and Pregnancy).
     
  • It is not known whether Gelnique passes through breast milk. Therefore, if you are breastfeeding or plan to start breastfeeding, discuss this with your healthcare provider prior to taking the drug (see Gelnique and Breastfeeding).
     
(Gelnique Warnings and Precautions Continued: Page 3)
Pages:

Previous 1 2 3 Next

Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;
Other Articles in This eMedTV Presentation